Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Radionuclide Generators × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 859 Carboplatin 805 Paclitaxel 792 Gemcitabine 661 Cisplatin 639 Docetaxel 603 Bevacizumab 537 Nivolumab 430 Pemetrexed 415 Cyclophosphamide 404 Capecitabine 398 Fluorouracil 340 Rituximab 336 Dexamethasone 336 Oxaliplatin 290 Injections 284 atezolizumab 266 Trastuzumab 262 Cetuximab 242 Leucovorin 234 Prednisone 220 Irinotecan 220 130-nm albumin-bound paclitaxel 218 Doxorubicin 210 Ipilimumab 201 Lenalidomide 196 Fulvestrant 188 fludarabine 181 durvalumab 177 Drug Therapy 172

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡